Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-03

Clinical Trial Update: Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating bladder capacity as an objective measure for intravesical treatment in newly diagnosed interstitial cystitis/painful bladder syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Endeavor Health | Conditions: Interstitial Cystitis, Painful Bladder Syndrome | Phase 4 | Status: COMPLETED